Malignant melanoma of unknown primary site in patient with pustulosis plantaris
Journal Title: OncoReview - Year 2014, Vol 4, Issue 2
Abstract
We reported a 57 year old woman treated for 2 years because of pustulosis plantaris (periodic exacerbations and remissions). In July 2013 she reported to the Outpatient Surgery because of a tumor in the left groin area. The biopsy revealed: metastases melanomatosis in lymphonodus. The patients was in October at the surgical removal of lymph nodes from left groin area (lymphadenectomy groin - ilio - obturatorii right). Full diagnostic was carried out and searching of of primary foci to no results. In the patient revealed the presence of BRAF and she was qualified to study of drug vemurafenib.
Authors and Affiliations
Piotr Brzeziński, Ahmad Abdulaziz, Jacek Andruszkiewicz, Anca Chiriac
Keywords
Related Articles
- EP ID EP67754
- DOI -
- Views 214
- Downloads 0
Mindfulness in the treatment of chronic pain and improvement in the quality of life of both oncological and non-oncological patients
Pain, which accompanies almost every third Pole, is an ever greater medical, psychological and social challenge. Relieving pain, and chronic one in particular, is now becoming one of the most important tasks for contempo...
Cisplatin-induced cardiotoxicity – two case reports
Cisplatin has been used for over 40 years in various cancer chemotherapies. Toxicity induced by cisplatin-based therapeutic regimens include gastrointestinal toxicity, myelotoxicity, neurotoxicity, ototoxicity and nephro...
Treatment of multiple superficial basal cell carcinomas with topical imiquimod
Basal cell carcinoma is the most common malignancy of man. The use of the topical imiquimod 5% cream offers a noninvasive, nonsurgical, and an effective option for the treatment of primary types superficial basal cell ca...
Remote consequences of polychemical and radiation therapy: cardiac valve disease complicated by infective endocarditis. Diagnostic and management problems
One of the quite frequent long-term effects of radiation therapy of malignant tumors, such as breast cancer and Hodgkin’s lymphoma primarily, when the irradiation of the mediastinum is performed, is the development of ra...
Novel oral anticoagulants in the treatment of cancer patients
Cancer and its treatment are well-recognized risk factors for venous thromboembolism. The risk of thrombotic complications increases 4–7-fold in cancer patients and coexistence of both pathologies is associated with shor...